These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16219636

  • 1. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
    Kim IJ, Kang HC, Jang SG, Kim K, Ahn SA, Yoon HJ, Yoon SN, Park JG.
    Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636
    [Abstract] [Full Text] [Related]

  • 2. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D, Rengucci C, Seymour I, Lattuneddu A, Polifemo AM, Monti F, Saragoni L, Amadori D.
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [Abstract] [Full Text] [Related]

  • 3. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R.
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [Abstract] [Full Text] [Related]

  • 4. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
    Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, Gauger P, Doherty G, Thompson NW, Hanash S, Koenig RJ, Nikiforov YE.
    Oncogene; 2005 Oct 06; 24(44):6646-56. PubMed ID: 16007166
    [Abstract] [Full Text] [Related]

  • 5. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
    Noda H, Kato Y, Yoshikawa H, Arai M, Togashi K, Nagai H, Konishi F, Miki Y.
    J Exp Clin Cancer Res; 2006 Jun 06; 25(2):235-42. PubMed ID: 16918136
    [Abstract] [Full Text] [Related]

  • 6. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL, Durocher J, Sanders C, Walters K, Culver K.
    Ann N Y Acad Sci; 2004 Jun 06; 1022():250-6. PubMed ID: 15251969
    [Abstract] [Full Text] [Related]

  • 7. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G.
    Clin Endocrinol (Oxf); 2008 Apr 06; 68(4):618-34. PubMed ID: 18070147
    [Abstract] [Full Text] [Related]

  • 8. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep 06; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 9. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study.
    Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC.
    Cancer Epidemiol Biomarkers Prev; 2010 Jul 06; 19(7):1831-9. PubMed ID: 20570909
    [Abstract] [Full Text] [Related]

  • 10. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
    Matos P, Oliveira C, Velho S, Gonçalves V, da Costa LT, Moyer MP, Seruca R, Jordan P.
    Gastroenterology; 2008 Sep 06; 135(3):899-906. PubMed ID: 18602919
    [Abstract] [Full Text] [Related]

  • 11. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J, Lagerstedt-Robinsson K, Påhlman L, Lindblom A.
    Cancer Epidemiol Biomarkers Prev; 2006 Nov 06; 15(11):2270-3. PubMed ID: 17119056
    [Abstract] [Full Text] [Related]

  • 12. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R, Schwartz S.
    Oncogene; 2005 Nov 17; 24(51):7630-4. PubMed ID: 16007118
    [Abstract] [Full Text] [Related]

  • 13. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation.
    Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Young J, Leggett BA, Jass JR, Tanaka N, Matsubara N.
    J Clin Oncol; 2004 Nov 15; 22(22):4584-94. PubMed ID: 15542810
    [Abstract] [Full Text] [Related]

  • 14. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY.
    Cancer Res; 2002 Nov 15; 62(22):6451-5. PubMed ID: 12438234
    [Abstract] [Full Text] [Related]

  • 15. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S, Alexiadis M, Fuller PJ.
    Gynecol Oncol; 2004 Dec 15; 95(3):603-9. PubMed ID: 15581971
    [Abstract] [Full Text] [Related]

  • 16. Microarray expression profiling in melanoma reveals a BRAF mutation signature.
    Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M, Hayward NK.
    Oncogene; 2004 May 20; 23(23):4060-7. PubMed ID: 15048078
    [Abstract] [Full Text] [Related]

  • 17. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers.
    Park HW, Kang HC, Kim IJ, Jang SG, Kim K, Yoon HJ, Jeong SY, Park JG.
    Int J Cancer; 2007 Jan 01; 120(1):7-12. PubMed ID: 17013898
    [Abstract] [Full Text] [Related]

  • 18. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
    Dadzie OE, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M.
    Br J Dermatol; 2009 Feb 01; 160(2):368-75. PubMed ID: 18945298
    [Abstract] [Full Text] [Related]

  • 19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 01; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 20. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S.
    J Med Genet; 2004 Sep 01; 41(9):664-8. PubMed ID: 15342696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.